$3.22
-21%Safety Shot, Inc. provides over-the-counter products and consumer products in the United States. The company offers Safety Shot Beverage, an over-the-counter drink that lowers blood alcohol content. It also provides hair loss treatment, vitiligo solution, eczema cream, and sexual wellness products. It sells its products through direct customers, distributors, retailers, and e-commerce websites. The company was formerly known as Jupiter Wellness, Inc. and changed its name to Safety Shot, Inc. in September 2023. Safety Shot, Inc. was incorporated in 2018 and is based in Jupiter, Florida.
Weak cash conversion. Significant portion of earnings not converting to cash—review working capital trends and capital intensity.
Asset-light business model. Low capital requirements leave more cash available for shareholders and growth investments.
Significant FCF decline raises concerns. Urgent review needed of operational performance and capital allocation.
Working capital inflow boosted cash flow. Efficient management of receivables, inventory, and payables contributing positively.
Deteriorating cash generation: Both declining FCF and weak conversion rate signal fundamental challenges. Investigate margin pressure, rising costs, or working capital issues.
BNKK • NASDAQ
| Bonk, Inc. Cash Flow Statement | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|
OPERATING ACTIVITIES | |||||
-48.4M | -14.8M | -15.6M | -28.1M | -6.3M | |
428.8K | 214.1K | 20.6K | 187.9K | 161.4K | |
5.1M | 1.1M | 3.2M | 9.4M | 2.4M | |
21.9M | 4.9M | 5M | 11.2M | 1M | |
1.8M | -1.5M | 941K | -251.1K | -44.2K | |
-19.1M | -10.1M | -6.4M | -7.6M | -2.7M | |
INVESTING ACTIVITIES | |||||
-85.7K | -2.2M | -15K | -88.3K | -44K | |
(0.0) | -390.5K | (0.0) | (0.0) | -202K | |
-739.6K | -545.1K | (0.0) | (0.0) | (0.0) | |
490K | 1.3M | 0.0 | 0.0 | 0.0 | |
330.3K | 1.5M | -2.5M | -13.1M | 0.0 | |
-4.9K | -330K | -2.5M | -13.1M | -246K | |
FINANCING ACTIVITIES | |||||
14.6M | 13.5M | -2.9M | 28.3M | 6.4M | |
0.0 | 42.7K | 2M | -182.5K | 659.6K | |
(0.0) | (0.0) | -2.9M | (0.0) | (0.0) | |
1M | -700K | -1.4K | 70.8K | -300K | |
15.6M | 12.8M | -904.2K | 28.2M | 6.7M | |
CASH FLOW SUMMARY | |||||
-3.5M | 2.4M | -9.7M | 7.5M | 3.7M | |
3.8M | 1.5M | 11.2M | 4.3M | 531K | |
348.8K | 3.8M | 1.5M | 11.8M | 4.3M | |
-19.2M | -12.3M | -6.4M | -7.8M | -2.8M |
BNKK - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
S-1 S-1 N/A | December 10, 2025 | December 10, 2025 | ||
8-K 8-K 2025 N/A | December 08, 2025 | December 03, 2025 | 2025 | |
DEF 14A DEF 14A 2025 N/A | December 01, 2025 | December 01, 2025 | 2025 | |
10-Q 10-Q 2025 Q3 Q3 | November 19, 2025 | September 30, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 07, 2025 | November 04, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 06, 2025 | November 05, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 04, 2025 | October 31, 2025 | 2025 | |
8-K/A 8-K/A 2025 (Amended) N/A | October 16, 2025 | August 25, 2025 | 2025 | |
8-K 8-K 2025 N/A | October 14, 2025 | October 08, 2025 | 2025 | |
8-K 8-K 2025 N/A | October 08, 2025 | October 03, 2025 | 2025 |
Continue your BNKK research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.